SR

Seetha Ramachanthiran

Active Director Designated Partner DIN 08020543
DIN 08020543 First appointment Feb 2018 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Seetha Ramachanthiran

Data last updated:

Seetha Ramachanthiran is a Designated Partner at Dusun Pharma Llp (since 2018). The company operates in Business Services.

DIN 08020543
Primary Designation Designated Partner
Industry Business Services
First Appointment 20 Feb 2018
Oldest Company Age 8 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Dusun Pharma Llp AAM-0579
Designated Partner20 Feb 20182018Active

Board colleagues of Seetha Ramachanthiran

NameDINCompanyDesignation
Bhuvaneshwari Vasantha Narayanan08020484Dusun Pharma LlpDesignated Partner
Ramya08020530Dusun Pharma LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Dusun Pharma Llp
Premium access

Shareholding and investment profile for Seetha Ramachanthiran

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Seetha Ramachanthiran

Seetha Ramachanthiran currently holds 1 directorship: Dusun Pharma Llp (Designated Partner, since 20 Feb 2018).

Seetha Ramachanthiran was first appointed on 20 Feb 2018 as Designated Partner at Dusun Pharma Llp.

The current boards of Seetha Ramachanthiran's companies include Bhuvaneshwari Vasantha Narayanan (Dusun Pharma Llp), Ramya (Dusun Pharma Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available